FDA green-lights bionic pancreas studied at UT Health Science Center, University Health

May 25, 2023

Artificial intelligence insulin delivery and glucose monitoring system cleared for age 6 and older While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the U.S. Food and Drug Administration, will relieve youth and their parents of constant worries over estimating insulin doses and […]

FDA green-lights bionic pancreas studied at UT Health Science Center, University Health

May 25, 2023

Artificial intelligence insulin delivery and glucose monitoring system cleared for age 6 and older Contact: Will Sansom, UT Health Science Center, 210-567-2579, sansom@uthscsa.edu University Health communications, 210-358-2335 SAN ANTONIO (May 25, 2023) — While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the […]

Mays Cancer Center conducts only clinical trial in America of a specific drug combination for lethal brain cancer glioblastoma

May 23, 2023

An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, one of the four National Cancer […]

Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at The University of Texas Health Science Center at San Antonio about the study drug donanemab

May 23, 2023

  Alicia S. Parker, MD, of The University of Texas Health Science Center at San Antonio, is assistant professor of cognitive and behavioral neurology and clinic director for the health science center’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. The Biggs Institute, in partnership with The University of Texas Rio Grande Valley, is Texas’ […]

Mays Cancer Center conducts only clinical trial in America of a specific drug combination for lethal brain cancer glioblastoma

May 23, 2023

An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 23, 2023) — The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma […]

Statement by the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases about the study drug donanemab

May 22, 2023

Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 22, 2023) — Alicia S. Parker, MD, of The University of Texas Health Science Center at San Antonio, is assistant professor of cognitive and behavioral neurology and clinic director for the health science center’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. The Biggs Institute, in […]